Eustachian Tube Dysfunction Treatment Market, Global Outlook and Forecast 2022-2028

August 2022 | 66 pages | ID: E3CE102FF0F6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Eustachian Tube Dysfunction Treatment in Global, including the following market information:

Global Eustachian Tube Dysfunction Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Eustachian Tube Dysfunction Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Eustachian Tube Dysfunction Treatment include Novartis AG, Mylan N.V, Bristol-Myers Squibb, Pfizer Inc., Bayer AG, Sanofi S.A., Johnson & Johnson Services, Inc., GlaxoSmithKline plc and Amgen. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eustachian Tube Dysfunction Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Eustachian Tube Dysfunction Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Eustachian Tube Dysfunction Treatment Market Segment Percentages, by Type, 2021 (%)

• Oral
• Topical

Global Eustachian Tube Dysfunction Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Eustachian Tube Dysfunction Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Eustachian Tube Dysfunction Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Eustachian Tube Dysfunction Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Eustachian Tube Dysfunction Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Eustachian Tube Dysfunction Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• Mylan N.V
• Bristol-Myers Squibb
• Pfizer Inc.
• Bayer AG
• Sanofi S.A.
• Johnson & Johnson Services, Inc.
• GlaxoSmithKline plc
• Amgen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Eustachian Tube Dysfunction Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Eustachian Tube Dysfunction Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EUSTACHIAN TUBE DYSFUNCTION TREATMENT OVERALL MARKET SIZE

2.1 Global Eustachian Tube Dysfunction Treatment Market Size: 2021 VS 2028
2.2 Global Eustachian Tube Dysfunction Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Eustachian Tube Dysfunction Treatment Players in Global Market
3.2 Top Global Eustachian Tube Dysfunction Treatment Companies Ranked by Revenue
3.3 Global Eustachian Tube Dysfunction Treatment Revenue by Companies
3.4 Top 3 and Top 5 Eustachian Tube Dysfunction Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Eustachian Tube Dysfunction Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Eustachian Tube Dysfunction Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Eustachian Tube Dysfunction Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Eustachian Tube Dysfunction Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Eustachian Tube Dysfunction Treatment Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Topical
4.2 By Type - Global Eustachian Tube Dysfunction Treatment Revenue & Forecasts
  4.2.1 By Type - Global Eustachian Tube Dysfunction Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Eustachian Tube Dysfunction Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Eustachian Tube Dysfunction Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Eustachian Tube Dysfunction Treatment Revenue & Forecasts
  5.2.1 By Application - Global Eustachian Tube Dysfunction Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Eustachian Tube Dysfunction Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Eustachian Tube Dysfunction Treatment Market Size, 2021 & 2028
6.2 By Region - Global Eustachian Tube Dysfunction Treatment Revenue & Forecasts
  6.2.1 By Region - Global Eustachian Tube Dysfunction Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Eustachian Tube Dysfunction Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Eustachian Tube Dysfunction Treatment Revenue, 2017-2028
  6.3.2 US Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.3.3 Canada Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.3.4 Mexico Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Eustachian Tube Dysfunction Treatment Revenue, 2017-2028
  6.4.2 Germany Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.4.3 France Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.4.4 U.K. Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.4.5 Italy Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.4.6 Russia Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.4.8 Benelux Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Eustachian Tube Dysfunction Treatment Revenue, 2017-2028
  6.5.2 China Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.5.3 Japan Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.5.4 South Korea Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.5.6 India Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Eustachian Tube Dysfunction Treatment Revenue, 2017-2028
  6.6.2 Brazil Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.6.3 Argentina Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Eustachian Tube Dysfunction Treatment Revenue, 2017-2028
  6.7.2 Turkey Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.7.3 Israel Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Eustachian Tube Dysfunction Treatment Market Size, 2017-2028
  6.7.5 UAE Eustachian Tube Dysfunction Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis AG
  7.1.1 Novartis AG Corporate Summary
  7.1.2 Novartis AG Business Overview
  7.1.3 Novartis AG Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.1.4 Novartis AG Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.1.5 Novartis AG Key News
7.2 Mylan N.V
  7.2.1 Mylan N.V Corporate Summary
  7.2.2 Mylan N.V Business Overview
  7.2.3 Mylan N.V Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.2.4 Mylan N.V Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.2.5 Mylan N.V Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.3.4 Bristol-Myers Squibb Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Pfizer Inc.
  7.4.1 Pfizer Inc. Corporate Summary
  7.4.2 Pfizer Inc. Business Overview
  7.4.3 Pfizer Inc. Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.4.4 Pfizer Inc. Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Inc. Key News
7.5 Bayer AG
  7.5.1 Bayer AG Corporate Summary
  7.5.2 Bayer AG Business Overview
  7.5.3 Bayer AG Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.5.4 Bayer AG Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.5.5 Bayer AG Key News
7.6 Sanofi S.A.
  7.6.1 Sanofi S.A. Corporate Summary
  7.6.2 Sanofi S.A. Business Overview
  7.6.3 Sanofi S.A. Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.6.4 Sanofi S.A. Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sanofi S.A. Key News
7.7 Johnson & Johnson Services, Inc.
  7.7.1 Johnson & Johnson Services, Inc. Corporate Summary
  7.7.2 Johnson & Johnson Services, Inc. Business Overview
  7.7.3 Johnson & Johnson Services, Inc. Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.7.4 Johnson & Johnson Services, Inc. Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Services, Inc. Key News
7.8 GlaxoSmithKline plc
  7.8.1 GlaxoSmithKline plc Corporate Summary
  7.8.2 GlaxoSmithKline plc Business Overview
  7.8.3 GlaxoSmithKline plc Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.8.4 GlaxoSmithKline plc Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline plc Key News
7.9 Amgen
  7.9.1 Amgen Corporate Summary
  7.9.2 Amgen Business Overview
  7.9.3 Amgen Eustachian Tube Dysfunction Treatment Major Product Offerings
  7.9.4 Amgen Eustachian Tube Dysfunction Treatment Revenue in Global Market (2017-2022)
  7.9.5 Amgen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Eustachian Tube Dysfunction Treatment Market Opportunities & Trends in Global Market
Table 2. Eustachian Tube Dysfunction Treatment Market Drivers in Global Market
Table 3. Eustachian Tube Dysfunction Treatment Market Restraints in Global Market
Table 4. Key Players of Eustachian Tube Dysfunction Treatment in Global Market
Table 5. Top Eustachian Tube Dysfunction Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Eustachian Tube Dysfunction Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Eustachian Tube Dysfunction Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Eustachian Tube Dysfunction Treatment Product Type
Table 9. List of Global Tier 1 Eustachian Tube Dysfunction Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eustachian Tube Dysfunction Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Eustachian Tube Dysfunction Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Eustachian Tube Dysfunction Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Eustachian Tube Dysfunction Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Eustachian Tube Dysfunction Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis AG Corporate Summary
Table 31. Novartis AG Eustachian Tube Dysfunction Treatment Product Offerings
Table 32. Novartis AG Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Mylan N.V Corporate Summary
Table 34. Mylan N.V Eustachian Tube Dysfunction Treatment Product Offerings
Table 35. Mylan N.V Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Eustachian Tube Dysfunction Treatment Product Offerings
Table 38. Bristol-Myers Squibb Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Inc. Corporate Summary
Table 40. Pfizer Inc. Eustachian Tube Dysfunction Treatment Product Offerings
Table 41. Pfizer Inc. Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bayer AG Corporate Summary
Table 43. Bayer AG Eustachian Tube Dysfunction Treatment Product Offerings
Table 44. Bayer AG Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi S.A. Corporate Summary
Table 46. Sanofi S.A. Eustachian Tube Dysfunction Treatment Product Offerings
Table 47. Sanofi S.A. Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Services, Inc. Corporate Summary
Table 49. Johnson & Johnson Services, Inc. Eustachian Tube Dysfunction Treatment Product Offerings
Table 50. Johnson & Johnson Services, Inc. Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline plc Corporate Summary
Table 52. GlaxoSmithKline plc Eustachian Tube Dysfunction Treatment Product Offerings
Table 53. GlaxoSmithKline plc Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Corporate Summary
Table 55. Amgen Eustachian Tube Dysfunction Treatment Product Offerings
Table 56. Amgen Eustachian Tube Dysfunction Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Eustachian Tube Dysfunction Treatment Segment by Type in 2021
Figure 2. Eustachian Tube Dysfunction Treatment Segment by Application in 2021
Figure 3. Global Eustachian Tube Dysfunction Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Eustachian Tube Dysfunction Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Eustachian Tube Dysfunction Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Eustachian Tube Dysfunction Treatment Revenue in 2021
Figure 8. By Type - Global Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 12. US Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 24. China Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Eustachian Tube Dysfunction Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Eustachian Tube Dysfunction Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis AG Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Mylan N.V Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Inc. Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer AG Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi S.A. Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Services, Inc. Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline plc Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Eustachian Tube Dysfunction Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)